1. Home
  2. RVPH vs BODI Comparison

RVPH vs BODI Comparison

Compare RVPH & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • BODI
  • Stock Information
  • Founded
  • RVPH 2006
  • BODI 1998
  • Country
  • RVPH United States
  • BODI United States
  • Employees
  • RVPH N/A
  • BODI N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • BODI Industrial Machinery/Components
  • Sector
  • RVPH Health Care
  • BODI Industrials
  • Exchange
  • RVPH Nasdaq
  • BODI Nasdaq
  • Market Cap
  • RVPH 26.6M
  • BODI 25.4M
  • IPO Year
  • RVPH N/A
  • BODI N/A
  • Fundamental
  • Price
  • RVPH $0.46
  • BODI $4.55
  • Analyst Decision
  • RVPH Strong Buy
  • BODI Buy
  • Analyst Count
  • RVPH 5
  • BODI 2
  • Target Price
  • RVPH $9.00
  • BODI $10.00
  • AVG Volume (30 Days)
  • RVPH 3.2M
  • BODI 16.5K
  • Earning Date
  • RVPH 08-13-2025
  • BODI 08-05-2025
  • Dividend Yield
  • RVPH N/A
  • BODI N/A
  • EPS Growth
  • RVPH N/A
  • BODI N/A
  • EPS
  • RVPH N/A
  • BODI N/A
  • Revenue
  • RVPH N/A
  • BODI $371,113,000.00
  • Revenue This Year
  • RVPH N/A
  • BODI N/A
  • Revenue Next Year
  • RVPH N/A
  • BODI N/A
  • P/E Ratio
  • RVPH N/A
  • BODI N/A
  • Revenue Growth
  • RVPH N/A
  • BODI N/A
  • 52 Week Low
  • RVPH $0.30
  • BODI $3.38
  • 52 Week High
  • RVPH $4.28
  • BODI $8.71
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 46.82
  • BODI 61.36
  • Support Level
  • RVPH $0.44
  • BODI $4.30
  • Resistance Level
  • RVPH $0.53
  • BODI $4.79
  • Average True Range (ATR)
  • RVPH 0.04
  • BODI 0.30
  • MACD
  • RVPH 0.02
  • BODI 0.05
  • Stochastic Oscillator
  • RVPH 56.07
  • BODI 67.27

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

About BODI The Beachbody Company Inc. Class A Common Stock

The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.

Share on Social Networks: